Advertisement
Advertisement
CSTL
Castle Biosciences Inc
27.72
USD+0.24
+0.87%
Dec 24, 14:48 UTC -5
Closed
...
Castle Biosciences Inc Profile
About
Info & Links
CEO
Derek J. Maetzold
Headquarters
Friendswood, TX 77546, UNITED STATES
Industry
Sector
Auditor
KPMG LLP
Share holders
132
Employees
610
Castle Biosciences Inc Statistics
Valuation Measures
Market Capitalization2
776.44M
Enterprise Value
691.49M
Enterprise Value/EBITDA(ttm)
121.25
Price to Earnings Ratio(ttm)
137.65
Price to Sales(ttm)
2.47
Price to Book(mrq)
1.75
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
81.82%
Operating Margin(ttm)
1.95%
Profit Margin(ttm)
1.38%
Return on Equity(ttm)
1.47%
Return on Invested Capital(ttm)
1.29%
Return on Assets(ttm)
1.27%
Income Statement
Revenue(ttm)
311.88M
Revenue Per Share(ttm)
11.14
Gross Profit(ttm)
255.43M
EBITDA(ttm)3
5.70M
Net Income Available to Common(ttm)
6.08M
Diluted EPS(ttm)
0.20
Share Statistics
Beta (5Y Monthly)
0.92
52-Week Change
38.95%
S&P 500 52-Week Change
26.50%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
28.01M
Dividend Yield
0.00%
Float4
25.99M
% Held by Insiders
7.20%
% Held by Institutions
92.60%
Balance Sheet
Total Cash(mrq)
279.79M
Total Cash Per Share(mrq)
9.99
Total Debt(mrq)
10.02M
Total Debt/Equity(mrq)
2.27%
Current Ratio(mrq)
7.78%
Quick Ratio(mrq)
7.64%
Book Value Per Share(mrq)
15.77
Cash Flow
Operating Cash Flow Per Share(ytd)
1.38
Free Cash Flow(ytd)
19.75M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement